Many HPAPIs require multiple process steps for synthesis, each of which must take worker safety into consideration while still delivering a robust process for scale-up. Join us as Dr. Adam Myers, Robert Farner and Jason Plassard discuss the safety and special process engineering capabilities required for such complex projects.
In the second webinar in our series, you can learn Evonik’s approach to implementing new HPAPI processes in our labs while assuring worker safety. Our speakers will walk you through a case study of a new chemical entity that was safely and successfully transferred into our development labs, further optimized, analyzed, and scaled to kilogram production. We will discuss the physical handling of the product during lab development and optimization, the analytical preparations and handling, and the design concepts of a kilo-scale facility.
This webinar is suitable for anyone in external HPAPI development outsourcing, procurement, engineering, EHS, industrial hygiene, project management, QC or analytical chemistry, who is interested in learning more about HPAPI handling in laboratory settings.Key learnings for participants of this webinar:
- Case example of transfer of an HPAPI to development labs and kilo-scale production
- Understanding of interplay between EHS, engineering, chemistry, analytical and quality for complex projects
- HPAPI implications for analytical chemistry
Related webinars in this series
This is the second webinar of our 3-part webinar series entitled "Handling HPAPIs: From toxicological risk assessment to metric ton manufacturing". Join us to follow the journey of a highly potent molecule, starting from toxicological assessment to initial tech transfer and development onto large scale (metric ton) commercial manufacture.
To learn more about the two other webinars in this series please click on the respective webinar below. To register for multiple webinars of this series simply select them in the registration form.